Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Gilead Sciences, Inc. (GILD) had Revenue of $28.75B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$28.75B
Net Income	$480.00M
Cost of Goods Sold	$6.25B
Gross Profit	$22.50B
Operating Expenses	$27.09B
Operating Income	$1.66B
Non-Operating Income/Expense	$-971.00M
Pre-Tax Income	$690.00M
Normalized Pre-Tax Income	$690.00M
Income after Taxes	$479.00M
Income from Continuous Operations	$479.00M
Consolidated Net Income/Loss	$480.00M
Normalized Income after Taxes	$479.00M
EBIT	$1.66B
EBITDA	$4.43B
Weighted-Average Shares Outstanding (Basic)	1.25B
Weighted-Average Shares Outstanding (Diluted)	1.25B
Earnings per Share (EPS) (Basic)	$0.38
Earnings per Share (EPS) (Diluted)	$0.38
Balance Sheet Financials
Current Assets	$19.17B
Property, Plant, and Equipment	$5.41B
Long-Term Assets	$39.82B
Total Assets	$58.99B
Current Liabilities	$12.00B
Long-Term Debt	$26.19B
Long-Term Liabilities	$27.75B
Total Liabilities	$39.75B
Common Equity	$19.25B
Tangible Shareholders Equity	$-9.02B
Shareholders Equity	$19.25B
Common Shares Outstanding	1.25B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$10.83B
Cash Flow from Investing Activities	$-3.45B
Cash Flow from Financial Activities	$-3.43B
Beginning Cash	$6.08B
End Cash	$9.99B
Increase/Decrease in Cash	$3.91B
Stock-Based Compensation	$835.00M
Common Stock Dividends Paid	$-3.92B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.58
Debt to Equity Ratio	1.46
Gross Margin	78.26%
Operating Margin	5.78%
EBIT Margin	5.78%
EBITDA Margin	15.40%
Pre-Tax Profit Margin	2.40%
Profit Margin	1.67%
Free Cash Flow	$10.30B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	3.66
Receiveable Turnover	6.51
Days Sales in Receivables	56.11
Return on Equity	2.49%
Return on Tangible Equity	-5.31%
Return on Assets	0.81%
Return on Investments	1.05%
Book Value Per Share	$15.45
Free Cash Flow per Share	$8.21
Operating Cash Flow per Share	$8.63

Data from Zacks Investment Research, Inc.